Benitec Biopharma Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q2 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Benitec Biopharma Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2019 to Q2 2024.
- Benitec Biopharma Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending June 30, 2024 was $14.5M, a 21.3% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)